Certified by Founder Lodge
Venrock
United States - Palo Alto, CA
INVESTOR
1 Disclosed Funding Rounds $40,000,000
29 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Venrock partners with entrepreneurs who want to tackle big, hard problems that most think not possible. For more information, please visit www.venrock.com or follow the firm on Twitter at @Ve
| Company | Date | Round | Raised |
|---|---|---|---|
 Quiq |
April, 12 ,2022 | Series C | $25,000,000 |
 Nightfall AI |
August, 10 ,2022 | Series B | $40,000,000 |
 Astronomer |
March, 23 ,2022 | Series C | $213,000,000 |
 Dgraph Labs |
July, 20 ,2022 | Seed | $6,000,000 |
| Quiq |
April, 12 ,2022 | Series C | $25,000,000 |
 Zero Networks |
February, 22 ,2022 | Series A | $20,300,000 |
| Astronomer |
March, 23 ,2022 | Series C | $213,000,000 |
 Decodable |
February, 24 ,2022 | Series A | $20,000,000 |
| Zero Networks |
February, 22 ,2022 | Series A | $20,300,000 |
 Airspeed |
May, 08 ,2023 | Unknown | $7,500,000 |
| Decodable |
February, 24 ,2022 | Series A | $20,000,000 |
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Airspeed |
May, 08 ,2023 | Unknown | $7,500,000 |
 Moment |
September, 18 ,2023 | Series A | $17,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| Moment |
September, 18 ,2023 | Series A | $17,000,000 |
 Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
 Archetype AI |
April, 08 ,2024 | Seed | $13,000,000 |
| Accompany Health |
February, 01 ,2024 | Series A | $56,000,000 |
 Tembo(US) |
July, 03 ,2024 | Series A | $14,000,000 |
| Archetype AI |
April, 08 ,2024 | Seed | $13,000,000 |
| Tembo(US) |
July, 03 ,2024 | Series A | $14,000,000 |
 Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
 Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
 Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
 GenLogs |
February, 06 ,2025 | Series A | $14,600,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
